Tekla Life Sciences Investors (NYSE:HQL)
| 16.16 Delayed Data As of Aug 16 |  -0.15 / -0.92%Today’s Change | 13.03 Today|||52-Week Range 22.70 | -15.96% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Assets | Cash | 10.1K | 615.3K | 41.00 | -- | |
| Cash & Short Term Investments | 9.9M | 10.2M | 13.1M | -- | ||
| Receivables | Receivables | 9.9M | 18.1K | 11.2M | -- | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | -- | -- |
| Current Assets | Current Assets | -- | -- | -- | -- | -- |
| Total Assets | Other Assets | 400.2K | 719.4K | 825.4K | -- | |
| Total Assets | 417.6M | 468.3M | 478.5M | -- | ||
| Liabilities | Accrued Expenses | 170.5K | 185.6K | 155.2K | -- | |
| Other Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | Other Liabilities | 2.7M | 2.0M | 3.0M | -- | |
| Total Liabilities | 2.7M | 2.0M | 3.0M | -- | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | -- | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Equity | 415.0M | 466.4M | 475.5M | -- | ||
| Total Shareholder Equity | 415.0M | 466.4M | 475.5M | -- | ||
| Share Information | Common Shares Outstanding | 20.7M | 21.6M | 22.4M | -- | |
| Addtl. Info. | No data currently available for this section. | |||||
